Attendee search 

NovoDux is developing the next generation of innovative and unique compounds for a variety of human diseases using its patented multi-targeted technology. The  compounds enable therapeutic applications for different human diseases in the fields of oncology, infectious diseases and neurology.

BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world. 

Our client retention is unparalleled in the industry because we are much more than just the provider of quality diagnostics. We have grown primarily as a result of our differentiating business model which is both physician-centric – providing superior service and support – and clinically relevant – providing innovative and disruptive technology to improve patient outcomes. What makes us different from other labs is the added value we bring through personal attention and professional support and the effort we make to understand our clients’ needs. Our success comes from helping clinicians deliver premium services to the patients in their care – through a full menu of cost–conscious testing options and cutting edge technologies with clinically–relevant results, all in a medically and fiscally responsible manner. 

In addition, BioReference has pioneered the development of business solutions for our clients, providing data and analytics to help them operate at their fullest potential. 

The Laboratory services multiple markets through several specialized business units, each with its own dedicated sales team and highly-trained support personnel. These include women’s health, oncology, genetics and a lab division focused exclusively on the nation’s expanding Spanish-speaking populations.

Specialties

Clinical Diagnostics, Oncology, Women's Health, Genetic Testing

About the American Heart Association

The American Heart Association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. Founded by six cardiologists in 1924, our organization now includes more than 22.5 million volunteers and supporters. We fund innovative research, fight for stronger public health policies, and provide critical tools and information to save and improve lives. Our nationwide organization includes 156 local offices and more than 3,000 employees. We moved our national headquarters from New York to Dallas in 1975 to be more centrally located. The American Stroke Association was created as a division in 1997 to bring together the organization’s stroke-related activities.

What We Do: To improve the lives of all Americans, we provide public health education in a variety of ways. We’re the nation’s leader in CPR education training. We help people understand the importance of healthy lifestyle choices. We provide science-based treatment guidelines to healthcare professionals to help them provide quality care to their patients. We educate lawmakers, policymakers and the public as we advocate for changes to protect and improve the health of our communities.

Rockland Technimed Limited is a diagnostic imaging company, committed to the early diagnosis and treatment of ischemic injury, through its patented Oxy-17® metabolic magnetic resonance imaging medium.

Rockland Technimed Limited (RTL) is a theranostic imaging company committed to the early diagnosis and treatment of hypoxic injury through Oxy-17®, its patented metabolic magnetic resonance imaging medium.  RTL has the world’s largest production source of Oxy-17® Gas, an enriched form of naturally available oxygen, in compliance with the cGMP requirement for medical gases, and commercially available in the United States and European Union for more than 20 years.  RTL’s lead preclinical candidate, Oxy-17® Fusion, is the first ready-to-use intravenous formulation of Oxy-17® Gas and is currently in regulatory marketing studies in Germany (European Union) and the United States.  Oxy-17® Fusion will be commercialized in the United States by RTL, and in the European Union with Nukem Isotopes GmbH. 

Predictive intelligence

The insight you’ll gain from Mergermarket often doesn’t become public knowledge until 6-24 months after our journalists first report on it, giving you a large window of opportunity to take early action.

Our global team of dedicated M&A journalists uses its extensive network of industry contacts and executives to gather information about corporate strategy, providing a unique source of M&A intelligence.

League tables

Because we’re always up to speed on which advisors are working which M&A deals, our detailed ‘Who’s who in M&A’ league tables have become an industry standard among investment professionals.

As a Mergermarket subscriber, you can custom-build individual or house league tables to analyze firm performance and enhance your marketing, competitor analysis or pitch book efforts.

ECM

Our new ECM tab is more than just an origination tool. It’s an independent voice, delivering the ECM news and information you need, ahead of the market. Learn more about Mergermarket ECM.

 

Analysis

Our multilingual team of journalists monitors more than 3,000 global media sources daily, summarizing the most relevant stories to supplement the information our correspondents provide.

Deals database

Through Mergermarket, you can search a global library of historical M&A transactions with fully sourced financials and exit multiples. You can analyze volumes and values of M&A activity in specific regions or sectors to discover deal patterns and identify trends ahead of competitors.

Private equity portfolio

Using Mergermarket’s customizable Private Equity Search facility, you can analyze over 1,000 of the world’s biggest private equity firms, looking at current portfolio, historical exits, potential investments, firm profile, historical advisor and investment relationships, and rival bidders.

What our subscribers say

• "Being an international law firm, we value Mergermarket as an important resource for real time deal intelligence across borders."

  Dechert LL

Your healthcare business faces pressures far beyond escalating costs and competition. Complex regulations now require that you search for efficiencies, seek new ways to offer your services and migrate from paper to electronic data processing.

J.P. Morgan can help you meet those goals. For more than 30 years, we have worked with hospitals and health systems, insurers, private practices and nursing homes. Today, we serve:

• More than 1,100 hospitals,
• 10 of the top 10 health insurers,
• Thousands of physicians’ groups, third-party administrators and other healthcare organizations,
• The top five pharmacy benefit managers and
• Six of the top eight pharmacy retailers.

Our treasury products and services can help you accelerate cash flow and optimize your organization’s working capital. In addition, by using products we have specifically designed for the healthcare industry, you can improve the accuracy of the information you need for efficient payment and remittance processing. To learn more about these products, including Healthcare Link for Payers, Healthcare Link for Providers and Health Savings Accounts, see below.

Whether you are coping with the impact of healthcare reform, trying to reduce costs, seeking to improve margins or trying to increase your working capital, put the experience and knowledge of J.P. Morgan Treasury Services to work for your organization.

Healthcare LinkSM

Facilitate the movement from paper to electronic claim remittance processing. Our solution automates the capture and passage of electronic files of explanations of benefits (EOBs) for faster, more accurate posting into your patient accounting or practice management system while still supporting legacy paper processes. See how it can help you. 

Cushman & Wakefield is a global leader in commercial real estate services, helping clients transform the way people work, shop, and live. The firm’s 43,000 employees in more than 60 countries provides deep local and global insights that create significant value for occupiers and investors around the world.

Spécialisations

agency leasing, global occupier services, asset services, investment management (branded DTZ Investors), capital markets, project & development services, facility services (branded C&W Services), tenant representation and valuation & advisory

Seamless access to critical data. Customer support that never stops. 21st-century ingenuity combined with good old-fashioned integrity. That's Accessium. No matter what business you're in, our custom solutions will take your data efficiency and security to the next level.

Specialties

PACS/Radiology/Cardiac/Ortho Systems, HealthCare Information Technology, Moblie Application Integration, Network Security/Auditing, Server and Network Architecture/Design/Support